The human hepatocellular carcinoma cell lines Hep3B and Huh7 and the normal hepatocyte cell line THLE-2 were obtained from the American Type Culture Collection (Manassas, VA, USA). All cells were cultured in Dulbecco's modified Eagle's medium (DMEM; Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) containing 10% fetal bovine serum (FBS; Invitrogen; Thermo Fisher Scientific, Inc.) at 37°C in 5% CO₂.

Cells were plated onto a 60-mm dish, and following incubation for 24 h, the overexpression vector for miR-34a (sense, 5′-UGGCAGUGUCUUAGCUGGUUGU-3′ and antisense, 5′-AACCAGCUAAGACACUGCCAUU-3′) (Sangon Biotech Co., Ltd., Shanghai, China) or the scramble control miRNA (sense, 5′-UGUCAGCUUUGGAGCUGGUUGU-3′ and antisense, 5′-AACCUAAGAUGCCACCAGCAUU-3′) was transfected into the Hep3B and Huh7 cells using Lipofectamine 2000 transfection reagent (Thermo Fisher Scientific, Inc.). Following transfection for 48 h at 37°C, cells were prepared for additional analysis.

For cell invasion assay, the Transwell with Matrigel method was performed as previously described (14). Briefly, following transfection for 48 h, hepatocellular cells (5×10⁵/ml) were re-suspended in serum-free DMEM containing 0.01% bovine serum albumin (BSA; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) for an additional 24 h. The upper chamber of the Transwell plate was covered with serum-free DMEM supplemented with 50 mg/l Matrigel, and then air-dried at 4°C for 15 min. Then, 50 µl fresh serum-free DMEM medium containing 10 g/l BSA was added, and cultured for 30 min at 37°C. Following removal of this medium, 200 µl cell suspension was added into the upper chamber of the Transwell plate, and 600 µl complete DMEM culture supplemented with 10% FBS (Sigma-Aldrich; Merck KGaA). After 48 h of incubation at 37°C in 5% CO₂, the Transwell plate was washed with PBS buffer to remove the cells on the upper side of the microporous membrane, followed with fixation in ice-cold alcohol for 30 min. Non-migratory cells were removed from the upper surface of the filter with a cotton swab. Finally, the cells were stained with 0.1% crystal violet for 30 min at room temperature, and then decolorized with 33% acetic acid. The absorbance of eluents was observed at an optical density of 570 nm using a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Cells transfected with the control vector served as the negative control.

For the cell migration assay, the wound healing asssay was performed as previously described (15). Hep3B and Huh7 cells (1×10⁵) transfected with miR-34a overexpression or scramble controls were seeded in 24-well plates and grown overnight to achieve confluence. The monolayer cells were scratched using a 20 µl pipette tip to create the wound. The floating cells were removed by washing twice with PBS (Sigma-Aldrich; Merck KGaA). Subsequently, serum-free DMEM was added to permit wound healing. The rate of wound closure was assessed using images captured after 24 h. Image analysis was performed using Image-Pro Plus software version 6.0 (Media Cybernetics, Inc., Rockville, MD, USA).

Total RNA from the Hep3B or Huh7 cells was collected 48 h after transfection and isolated using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc., USA) as previously described (16). The samples were treated with RNase-free DNase I (Promega Corporation, Madison, WI, USA). Consequently, the concentration and purity for the isolated RNA were measured with SMA 400 UV-VIS (Merinton Instrument, Ltd., Beijing, China). Purified RNA at a density of 0.5 µg/µl with nuclease-free water was used for cDNA synthesis using the PrimerScript 1st Strand cDNA Synthesis kit (Invitrogen; Thermo Fisher Scientific, Inc.), with the following temperature protocol: 30°C for 10 min, 42°C for 50 min, and 95°C for 5 min. The expressions of targets in the cells were detected in an Eppendorf Mastercycler (Brinkmann Instruments, Westbury, NY, USA) using the SYBR ExScript RT-qPCR kit (Takara Bio, Inc., Otsu, Japan). The total reaction system of 20 µl volume was as follows: 1 µl cDNA from the above PCR, 10 µl SYBR Premix EX Taq, 1 µl each of the primers (10 µM), and 7 µl ddH₂O. The PCR thermocycler conditions were as follows: Denaturation at 50°C for 2 min; 95°C for 10 min; followed by 45 cycles of 95°C for 10 sec and 60°C for 1 min. Melting curve analysis of amplification products was performed at the end of each PCR to confirm that only one product was amplified and detected. These data were quantified using the 2^−ΔΔCq method (17). GAPDH was used as the internal control. Primers used for the amplification of the targets are listed in Table I.

Cells cultured for 48 h were lysed with radioimmunoprecipitation buffer (Sangon Biotech Co., Ltd.) containing phenylmethanesulfonyl fluoride (Sigma-Aldrich; Merck KGaA), and the lysates were then centrifuged at 12,000 × g for 10 min at 4°C. The supernatants were collected, and protein concentrations were determined using a bicinchoninic protein assay kit (Pierce; Thermo Fisher Scientific, Inc.). The proteins (30 µg/lane) were separated using SDS-PAGE on a 10% gel, as previously described (18) followed by transfer onto a polyvinylidene fluoride membrane (Merck KGaA). The membranes were blocked using Tris-buffered saline with 0.05% Tween-20 (TBST) containing 5% non-fat milk for 1 h at room temperature, and then incubated with rabbit anti-human antibodies [(purchased from Abcam (Cambridge, MA, USA)] against sirtuin 1 (SIRT1; cat. no. ab12193), tumor protein 53 (p53; cat. no. ab131442), acetylate-p53 (Ac-p53; cat. no. ab75754) and GAPDH (cat. no. ab37168; all 1:100) overnight at 4°C. Subsequently, the membranes were incubated with a horseradish peroxidase-conjugated goat anti-rabbit IgG secondary antibody (cat. no. ab205718; 1:5,000; Abcam) for 1 h at room temperature. Finally, the polyvinylidene fluoride membranes were washed 3 times with 1X TBST buffer for 10 min each time. The signals were detected following incubation of the membranes with a chromogenic substrate using the SuperSignal^® West Pico chemiluminescent western blotting substrate (Pierce; Thermo Fisher Scientific, Inc.). Analysis was performed using the Image Guage 4.0 program (Fuji, Tokyo, Japan). GAPDH served as the internal control.

All experiments were conducted independently 3 times. All data are presented as the mean ± standard deviation. The significant difference for the data was calculated using SPSS v19.0 statistical software. P-values were calculated using one-way analysis of variance followed by Duncan's multiple-range test. P<0.05 was considered to indicate a statistically significant difference.

The relative expression levels of miR-34a in THLE-2, Hep3B and Huh7 cells were assessed using RT-qPCR analysis (Fig. 1). The results demonstrated that miR-34a expression was significantly decreased in Hep3B and Huh7 cells compared with that in the THLE-2 cells (P<0.01; Fig. 1A). The present study further analyzed the expression of miR-34a in Hep3B and Huh7 cells following transfection with miR-34a overexpression vectors, and the results suggested that miR-34a was highly expressed in these cells by miR-34a overexpression transfection compared with miR-34a expression in scramble control cells (Huh7 cells, P<0.05; Hep3B cells, P<0.01; Fig. 1B).

When cells were transfected with miR-34a overexpression vectors, the number of migrated cells was significantly decreased compared with that for the scramble control group (P<0.01; Fig. 2). There was no significant difference between the number of migrated cells for the negative control group and that for the scramble treated cells.

The effect of miR-34a expression on hepatocellular cell invasion was also detected. The results suggested that the number of invasive cells was significantly decreased by the overexpression of miR-34a in Hep3B and Huh7 cells compared with that in the control group (P<0.01; Fig. 3). However, there was no significant difference in the number of invasive cells between control cells and the scramble treated cells.

To further investigate the potential mechanism underlying the effect of miR-34a on hepatocellular cell migration and invasion, the expression of proteins including SIRT1, p53 and Ac-p53 were analyzed (Fig. 4). The results demonstrated that the SIRT1 mRNA and protein levels were significantly decreased by the overexpression of miR-34a (P<0.01; Fig. 4A and B). The Ac-p53 protein level was significantly increased by the overexpression of miR-34a in Hep3B and Huh7 cells, compared with that in control cells (P<0.05; Fig. 4A and B).